VOR earnings date and last-quarter result: last quarter beat, P/E -0.03. Updated 2026-07-23.
Vor Biopharma (VOR) Research Hub
Vor Biopharma (VOR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 18.33 USD (+0.38%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.03, market cap 0.13B. This hub links to the full technical, earnings and options research available for VOR.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 18.33 USD (+0.38%) |
| 52-week range | 13.45 USD – 26 USD |
| Trend regime | Range |
| 14-day RSI | 50.2 (Neutral) |
| Trailing P/E | -0.03 |
| Market cap | 0.13B |
| Dividend yield | 0.00% |
Available research for VOR
Covered Call on VOR: how it works, illustrative setup around the real 18.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VOR: how it works, illustrative setup around the real 18.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VOR: how it works, illustrative setup around the real 18.33 USD price, max profit/loss, breakeven and when to use it. Educational.
VOR technical analysis: range, last 18.33 USD, RSI 50.2, 52w range 13.45 USD–26 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VOR in?
Vor Biopharma (VOR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VOR in an uptrend or downtrend?
As of 2026-10-26, VOR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VOR's trailing P/E ratio?
VOR's trailing P/E is -0.03, with a market cap of 0.13B. See the earnings research page for full valuation detail.